DAWN vs. SPRY
Compare and contrast key facts about Day One Biopharmaceuticals, Inc. (DAWN) and Silverback Therapeutics Inc (SPRY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DAWN or SPRY.
Correlation
The correlation between DAWN and SPRY is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
DAWN vs. SPRY - Performance Comparison
Key characteristics
DAWN:
-0.32
SPRY:
0.79
DAWN:
-0.14
SPRY:
1.42
DAWN:
0.98
SPRY:
1.17
DAWN:
-0.28
SPRY:
0.56
DAWN:
-0.78
SPRY:
2.81
DAWN:
21.31%
SPRY:
17.62%
DAWN:
51.93%
SPRY:
63.11%
DAWN:
-79.51%
SPRY:
-95.20%
DAWN:
-55.48%
SPRY:
-81.39%
Fundamentals
DAWN:
$1.25B
SPRY:
$1.09B
DAWN:
-$0.97
SPRY:
-$0.50
DAWN:
$101.95M
SPRY:
$2.57M
DAWN:
$99.54M
SPRY:
$2.43M
DAWN:
-$151.63M
SPRY:
-$50.25M
Returns By Period
In the year-to-date period, DAWN achieves a -1.89% return, which is significantly lower than SPRY's 6.54% return.
DAWN
-1.89%
0.40%
-11.78%
-14.63%
N/A
N/A
SPRY
6.54%
-17.05%
-13.27%
47.89%
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
DAWN vs. SPRY — Risk-Adjusted Performance Rank
DAWN
SPRY
DAWN vs. SPRY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Day One Biopharmaceuticals, Inc. (DAWN) and Silverback Therapeutics Inc (SPRY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
DAWN vs. SPRY - Dividend Comparison
Neither DAWN nor SPRY has paid dividends to shareholders.
Drawdowns
DAWN vs. SPRY - Drawdown Comparison
The maximum DAWN drawdown since its inception was -79.51%, smaller than the maximum SPRY drawdown of -95.20%. Use the drawdown chart below to compare losses from any high point for DAWN and SPRY. For additional features, visit the drawdowns tool.
Volatility
DAWN vs. SPRY - Volatility Comparison
The current volatility for Day One Biopharmaceuticals, Inc. (DAWN) is 11.01%, while Silverback Therapeutics Inc (SPRY) has a volatility of 15.95%. This indicates that DAWN experiences smaller price fluctuations and is considered to be less risky than SPRY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
DAWN vs. SPRY - Financials Comparison
This section allows you to compare key financial metrics between Day One Biopharmaceuticals, Inc. and Silverback Therapeutics Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities